180 related articles for article (PubMed ID: 32556844)
1. Influence of sampling schedules on [
Rinscheid A; Kletting P; Eiber M; Beer AJ; Glatting G
EJNMMI Phys; 2020 Jun; 7(1):41. PubMed ID: 32556844
[TBL] [Abstract][Full Text] [Related]
2. Technical Note: Optimal sampling schedules for kidney dosimetry based on the hybrid planar/SPECT method in
Rinscheid A; Kletting P; Eiber M; Beer AJ; Glatting G
Med Phys; 2019 Dec; 46(12):5861-5866. PubMed ID: 31587333
[TBL] [Abstract][Full Text] [Related]
3. A simulation-based method to determine optimal sampling schedules for dosimetry in radioligand therapy.
Rinscheid A; Lee J; Kletting P; Beer AJ; Glatting G
Z Med Phys; 2019 Dec; 29(4):314-325. PubMed ID: 30611606
[TBL] [Abstract][Full Text] [Related]
4. Single-time-point estimation of absorbed doses in PRRT using a non-linear mixed-effects model.
Hardiansyah D; Riana A; Beer AJ; Glatting G
Z Med Phys; 2023 Feb; 33(1):70-81. PubMed ID: 35961809
[TBL] [Abstract][Full Text] [Related]
5. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for
Peterson AB; Mirando DM; Dewaraja YK
EJNMMI Res; 2023 Jun; 13(1):57. PubMed ID: 37306783
[TBL] [Abstract][Full Text] [Related]
6. Investigation of image-based lesion and kidney dosimetry protocols for
Resch S; Takayama Fouladgar S; Zacherl M; Sheikh GT; Liubchenko G; Rumiantcev M; Unterrainer LM; Wenter V; Bartenstein P; Ziegler SI; Ilhan H; Beyer L; Böning G; Delker A
EJNMMI Phys; 2023 Feb; 10(1):11. PubMed ID: 36757516
[TBL] [Abstract][Full Text] [Related]
7. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in clinical patients and realistic simulations.
Peterson AB; Mirando DM; Dewaraja YK
Res Sq; 2023 Apr; ():. PubMed ID: 37131738
[No Abstract] [Full Text] [Related]
8. Dosimetry for (177)Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer.
Delker A; Fendler WP; Kratochwil C; Brunegraf A; Gosewisch A; Gildehaus FJ; Tritschler S; Stief CG; Kopka K; Haberkorn U; Bartenstein P; Böning G
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):42-51. PubMed ID: 26318602
[TBL] [Abstract][Full Text] [Related]
9. Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [
Hardiansyah D; Yousefzadeh-Nowshahr E; Kind F; Beer AJ; Ruf J; Glatting G; Mix M
J Nucl Med; 2024 Apr; 65(4):566-572. PubMed ID: 38423787
[TBL] [Abstract][Full Text] [Related]
10. Dependence of treatment planning accuracy in peptide receptor radionuclide therapy on the sampling schedule.
Maaß C; Sachs JP; Hardiansyah D; Mottaghy FM; Kletting P; Glatting G
EJNMMI Res; 2016 Dec; 6(1):30. PubMed ID: 27015662
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different methods for post-therapeutic dosimetry in [
Rosar F; Schön N; Bohnenberger H; Bartholomä M; Stemler T; Maus S; Khreish F; Ezziddin S; Schaefer-Schuler A
EJNMMI Phys; 2021 May; 8(1):40. PubMed ID: 33950333
[TBL] [Abstract][Full Text] [Related]
12. Clinical implementation of PLANET® Dose for dosimetric assessment after [
Santoro L; Pitalot L; Trauchessec D; Mora-Ramirez E; Kotzki PO; Bardiès M; Deshayes E
EJNMMI Res; 2021 Jan; 11(1):1. PubMed ID: 33394212
[TBL] [Abstract][Full Text] [Related]
13. Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA
Gosewisch A; Delker A; Tattenberg S; Ilhan H; Todica A; Brosch J; Vomacka L; Brunegraf A; Gildehaus FJ; Ziegler S; Bartenstein P; Böning G
EJNMMI Res; 2018 Aug; 8(1):76. PubMed ID: 30076556
[TBL] [Abstract][Full Text] [Related]
14. Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation.
Peters SMB; Mink MCT; Privé BM; de Bakker M; de Lange F; Muselaers CHJ; Mehra N; Witjes JA; Gotthardt M; Nagarajah J; Konijnenberg MW
EJNMMI Res; 2023 Jan; 13(1):6. PubMed ID: 36692682
[TBL] [Abstract][Full Text] [Related]
15. A step toward simplified dosimetry of radiopharmaceutical therapy via SPECT frame duration reduction.
Yazdani E; Asadi M; Geramifar P; Karamzade-Ziarati N; Vosoughi H; Kazemi-Jahromi M; Sadeghi M
Appl Radiat Isot; 2024 May; 210():111378. PubMed ID: 38820867
[TBL] [Abstract][Full Text] [Related]
16. Kidney absorbed radiation doses for [ 177 Lu]Lu-PSMA-617 and [ 177 Lu]Lu-PSMA-I&T determined by 3D clinical dosimetry.
Uijen MJM; Privé BM; van Herpen CML; Westdorp H; van Gemert WA; de Bakker M; Gotthardt M; Konijnenberg MW; Peters SMB; Nagarajah J
Nucl Med Commun; 2023 Apr; 44(4):270-275. PubMed ID: 36597884
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT.
Grob D; Privé BM; Muselaers CHJ; Mehra N; Nagarajah J; Konijnenberg MW; Peters SMB
EJNMMI Phys; 2024 Apr; 11(1):34. PubMed ID: 38568428
[TBL] [Abstract][Full Text] [Related]
18. Is a single late SPECT/CT based kidney
Beykan S; Tran-Gia J; Borup Jensen S; Lassmann M
Phys Med; 2022 Aug; 100():39-50. PubMed ID: 35724608
[TBL] [Abstract][Full Text] [Related]
19. 3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT.
Gosewisch A; Ilhan H; Tattenberg S; Mairani A; Parodi K; Brosch J; Kaiser L; Gildehaus FJ; Todica A; Ziegler S; Bartenstein P; Böning G
EJNMMI Res; 2019 Aug; 9(1):76. PubMed ID: 31414241
[TBL] [Abstract][Full Text] [Related]
20. Treatment planning in PRRT based on simulated PET data and a PBPK model. Determination of accuracy using a PET noise model.
Hardiansyah D; Guo W; Attarwala AA; Kletting P; Mottaghy FM; Glatting G
Nuklearmedizin; 2017 Feb; 56(1):23-30. PubMed ID: 27885372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]